Skip to main content
SpringerLink
Log in
Book cover

Gestational Trophoblastic Disease pp 1–14Cite as

Gestational Trophoblastic Disease: General Aspects

  • Chapter
  • First Online:

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

As a major defining characteristic of eutherian mammals, the placenta is a transient organ of female reproduction that nourishes the developing fetus through nutrient supply, waste elimination, and gas exchange. In both Latin and Greek, the placenta means flat cake, in reference to its flat and round appearance in human. The placenta arises from the same fertilized egg that forms the fetus and is essentially a fetomaternal organ consisting of two components: the fetal part (chorion frondosum) and the maternal part (decidua basalis). It has been speculated that ancestral mammals might have evolved to attain the placenta, along with newly acquired retrotransposon-derived genes, or expression of endogenous versions of the genes present in oviparous animals.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hedges SB. The origin and evolution of model organisms. Nat Rev Genet. 2002;3(11):838–49.

    PubMed  CAS  Google Scholar 

  2. Sebastian A. A dictionary of the history of medicine. NY: The Parthenon Publishing Group Inc; 1999.

    Google Scholar 

  3. Elliott JS. Outlines of greek and roman medicine. Boston: Milford House Inc; 1971.

    Google Scholar 

  4. Ricci J. The genealogy of gynaecology: history of the development of gynaecology throughout the ages 2000 BC - 1800 AD, with excerpts from the many authors who have contributed to the various phases of the subject. 2nd ed. Philadelphia: The Blakston Company; 1950.

    Google Scholar 

  5. Bondeson J, Molenkamp A. The countess margaret of henneberg and her 365 children. J R Soc Med. 1996;89(12):711–6. PMCID: 1296041.

    Google Scholar 

  6. Rather LJ, Ambroise Pare. The countess margaret, multiple births, and hydatidiform mole. Bull N Y Acad Med. 1971;47(5):508–15. PMCID: 1749900.

    Google Scholar 

  7. Brews A. Hydatidiform mole and chorion-epithelioma. J Obstet Gynaecol Br Commonw. 1939;46(5):22.

    Google Scholar 

  8. Brews A. Hydatidiform mole and chorion-epithelioma. J Obstet Gynaecol Br Emp. 1939;46(5):813–35.

    Google Scholar 

  9. Stewart CJ. History of gynecological pathology. VIII. John Hammond teacher. Int J Gynecol Pathol. 2000;19(3):284–92.

    PubMed  CAS  Google Scholar 

  10. Beach GW. IV. The deciduoma malignum. Ann Surg. 1895;21(5):525–42. PMCID: 1494170.

    Google Scholar 

  11. Ober WB, Fass RO. The early history of choriocarcinoma. J Hist Med Allied Sci. 1961;16:49–73.

    PubMed  CAS  Google Scholar 

  12. Dallenbach-Hellweg G, Schmidt D. History of gynecological pathology. VI. Jacob Felix Marchand. Int J Gynecol Pathol. 1999;18(3):281–7.

    PubMed  CAS  Google Scholar 

  13. Ewing J. Chorioma: a clinical pathological study. Surg Gynecol Obstet. 1910;10:26.

    Google Scholar 

  14. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature. 1977;268(5621):633–4.

    PubMed  CAS  Google Scholar 

  15. McGrath J, Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell. 1984;37(1):179–83.

    PubMed  CAS  Google Scholar 

  16. Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature. 1984;308(5959):548–50.

    PubMed  CAS  Google Scholar 

  17. Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ. Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet. 1993;53(5):1096–102. PMCID: 1682317.

    Google Scholar 

  18. Wake N, Arima T, Matsuda T. Involvement of IGF2 and H19 imprinting in choriocarcinoma development. Int J Gynaecol Obstet. 1998;60 Suppl 1:S1–8.

    PubMed  CAS  Google Scholar 

  19. Arima T, Matsuda T, Takagi N, Wake N. Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet. 1997;93(1):39–47.

    PubMed  CAS  Google Scholar 

  20. Lewis Jr JL. Chemotherapy of gestational choriocarcinoma. Cancer. 1972;30(6):1517–21.

    PubMed  Google Scholar 

  21. Li MC, Hertz R, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956;93:5.

    Google Scholar 

  22. Hertz R, Lewis Jr J, Lipsett MB. Five year’s experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol. 1961;82:631–40.

    PubMed  CAS  Google Scholar 

  23. Ross GT, Stolbach LL, Hertz R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res. 1962;22:1015–7.

    PubMed  CAS  Google Scholar 

  24. Ross GT, Goldstein DP, Hertz R, Lipsett MB, Odell WD. Sequential Use of Methotrexate and Actinomycin D in the Treatment of Metastatic Choriocarcinoma and Related Trophoblastic Diseases in Women. Am J Obstet Gynecol. 1965;93:223–9.

    PubMed  CAS  Google Scholar 

  25. Goldstein DP. The chemotherapy of gestational trophoblastic disease: principles of clinical management. JAMA. 1972;220(2):209–13.

    PubMed  CAS  Google Scholar 

  26. Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human ­chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972;113(6):751–8.

    PubMed  CAS  Google Scholar 

  27. Rayford PL, Vaitukaitis JL, Ross GT, Morgan FJ, Canfield RE. Use of specific antisera to characterize biologic activity of hCG-beta subunit preparations. Endocrinology. 1972;91(1):144–6.

    PubMed  CAS  Google Scholar 

  28. Fukuyama R, Takata M, Kudoh J, Sakai K, Tamura S, Shimizu N. DNA diagnosis of hydatidiform mole using the polymerase chain reaction. Hum Genet. 1991;87(2):216–8.

    PubMed  CAS  Google Scholar 

  29. Fisher RA, Newlands ES. Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol. 1993;168(2):563–9.

    PubMed  CAS  Google Scholar 

  30. Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol. 2008;32(3):445–51.

    PubMed  Google Scholar 

  31. McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33(6):805–17.

    PubMed  Google Scholar 

  32. Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, et al. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol. 2010;115(4):784–94.

    PubMed  Google Scholar 

  33. Benirschke K, Kaufmann P, Baergen RN. Pathology of the human placenta. 5th ed. NY: Springer; 2006.

    Google Scholar 

  34. Benirschke K. What’s new in gestational trophoblastic disease? Gen Diagn Pathol. 1997;143(2–3):85–6.

    PubMed  CAS  Google Scholar 

  35. Tavassoli F, Peter D. World Health Organization: tumours of the breast and female genital organs. Lyon: IARC PRESS; 2004.

    Google Scholar 

  36. Marchand F. Uber den Bau der Blasenmole. Z Geburtshilfe Gynakol. 1898;32:67.

    Google Scholar 

  37. Tham KF, Ratnam SS. The classification of gestational trophoblastic disease: a critical review. Int J Gynaecol Obstet. 1998;60 Suppl 1:S39–49.

    PubMed  Google Scholar 

  38. Hancock BW. Staging and classification of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):869–83.

    PubMed  Google Scholar 

  39. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20(1):31–47.

    PubMed  CAS  Google Scholar 

  40. Buckley JD. The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynecol. 1984;27(1):153–9.

    PubMed  CAS  Google Scholar 

  41. Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol. 2001;20(4):315–22.

    PubMed  CAS  Google Scholar 

  42. Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360(16):1639–45.

    PubMed  CAS  Google Scholar 

  43. Wei PY, Ouyang PC. Trophoblastic diseases in Taiwan. A review of 157 cases in a 10 year period. Am J Obstet Gynecol. 1963;85:844–9.

    PubMed  CAS  Google Scholar 

  44. Acosta-Sison H. Observations which may indicate the etiology of hydatidiform mole and explain its high incidence in the Philippines and Asiatic countries. Philipp J Surg Surg Spec. 1959;14:290–3.

    PubMed  CAS  Google Scholar 

  45. Shang ER. A retrospective investigation on the ­incidence of hydatidiform mole in 20,548 fertile women. Zhonghua Yi Xue Za Zhi. 1982;62(5):282–5.

    PubMed  CAS  Google Scholar 

  46. Song HZ, Wu PC. Hydatidiform mole in China: a preliminary survey of incidence on more than three million women. Bull World Health Organ. 1987;65(4):507–11. PMCID: 2491037.

    Google Scholar 

  47. Nakano R, Sasaki K, Yamoto M, Hata H. Trophoblastic disease: analysis of 342 patients. Gynecol Obstet Invest. 1980;11(4):237–42.

    PubMed  CAS  Google Scholar 

  48. Honda J, Yanagida K, Sato E, Sugawara N, Munakata S, Fukushima T. Incidence of hydatidiform mole and aging of mothers (author’s transl). Nippon Sanka Fujinka Gakkai Zasshi. 1982;34(7):915–9.

    PubMed  CAS  Google Scholar 

  49. Takeuchi S. Incidence of gestational trophoblastic disease by regional registration in Japan. Hum Reprod. 1987;2(8):729–34.

    PubMed  CAS  Google Scholar 

  50. Hayashi K, Bracken MB, Freeman Jr DH, Hellenbrand K. Hydatidiform mole in the United States (1970-1977): a statistical and theoretical analysis. Am J Epidemiol. 1982;115(1):67–77.

    PubMed  CAS  Google Scholar 

  51. Atrash HK, Hogue CJ, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986;154(4):906–9.

    PubMed  CAS  Google Scholar 

  52. Hertig AT, Sheldon WH. Hydatidiform mole; a pathologico-clinical correlation of 200 cases. Am J Obstet Gynecol. 1947;53(1):1–36.

    PubMed  CAS  Google Scholar 

  53. Slocumb JC, Lund CJ. Incidence of trophoblastic disease: increased rate in youngest age group. Am J Obstet Gynecol. 1969;104(3):421–3.

    PubMed  CAS  Google Scholar 

  54. Douglas GW. The diagnosis and management of hydatidiform mole. Surg Clin North Am. 1957;37(2):379–92.

    PubMed  CAS  Google Scholar 

  55. Womack C, Elston CW. Hydatidiform mole in Nottingham: a 12-year retrospective epidemiological and morphological study. Placenta. 1985;6(2):93–105.

    PubMed  CAS  Google Scholar 

  56. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet. 1986;2(8508):673–7.

    PubMed  CAS  Google Scholar 

  57. Mazzanti P, La Vecchia C, Parazzini F, Bolis G. Frequency of hydatidiform mole in Lombardy, Northern Italy. Gynecol Oncol. 1986;24(3):337–42.

    PubMed  CAS  Google Scholar 

  58. Franke HR, Risse EK, Kenemans P, Vooijs GP, Stolk JG. Epidemiologic features of hydatidiform mole in the Netherlands. Obstet Gynecol. 1983;62(5):613–6.

    PubMed  CAS  Google Scholar 

  59. Flam F, Lundstrom-Lindstedt V, Rutqvist LE. Incidence of gestational trophoblastic disease in Stockholm County, 1975-1988. Eur J Epidemiol. 1992;8(2):173–7.

    PubMed  CAS  Google Scholar 

  60. Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965. Acta Obstet Gynecol Scand. 1970;49(2):195–203.

    PubMed  CAS  Google Scholar 

  61. Stevenson AC, Dudgeon MY, Mc CH. Observations on the results of pregnancies in women resident in Belfast. II. Abortions, hydatidiform moles and ectopic pregnancies. Ann Hum Genet. 1959;23:395–414.

    PubMed  CAS  Google Scholar 

  62. Duff GB. Gestational trophoblastic disease in New Zealand, 1980-1986. Aust N Z J Obstet Gynaecol. 1989;29(2):139–42.

    PubMed  CAS  Google Scholar 

  63. Olesnicky G, Long AR, Quinn MA, Pepperell RJ, Fortune DW, Kneale BL. Hydatidiform mole in Victoria: aetiology and natural history. Aust N Z J Obstet Gynaecol. 1985;25(1):1–7.

    PubMed  CAS  Google Scholar 

  64. Paksoy N, Reich B. The occurrence of trophoblastic disease in Western Samoa. N Z Med J. 1989;102(865):162–3.

    PubMed  CAS  Google Scholar 

  65. Steigrad SJ. The incidence of neoplastic trophoblastic disease in Australia. Aust N Z J Obstet Gynaecol. 1969;9(2):100–2.

    PubMed  CAS  Google Scholar 

  66. Beischer NA, Bettinger HF, Fortune DW, Pepperell R. Hydatidiform mole and its complications in the state of Victoria. J Obstet Gynaecol Br Commonw. 1970;77(3):263–76.

    PubMed  CAS  Google Scholar 

  67. Ogunbode O. Benign hydatidiform mole in Ibadan, Nigeria. Int J Gynaecol Obstet. 1978;15(5):387–90.

    PubMed  CAS  Google Scholar 

  68. Agboola A. Trophoblastic neoplasia in an african urban population. J Natl Med Assoc. 1979;71(10):935–7. PMCID: 2537523.

    Google Scholar 

  69. Ayangade O. Gestational trophoblastic disease in Nigeria – A 10 year review. East Afr Med J. 1979;56(6):278–82.

    PubMed  CAS  Google Scholar 

  70. Diejomaoh FM, Omu AE, Okpere EE, Ezimokhai M, Tabowei O, Ajabor LN. The problems of management of gestational trophoblastic neoplasms at the University of Benin Teaching Hospital, Benin City, Nigeria. Adv Exp Med Biol. 1984;176:417–28.

    PubMed  CAS  Google Scholar 

  71. Egwuatu VE, Ozumba BC. Observations on molar pregnancy in Enugu, Nigeria. Int J Gynaecol Obstet. 1989;29(3):219–25.

    PubMed  CAS  Google Scholar 

  72. Rolon PA, Hochsztajn B, Llamosas F. Epidemiology of complete hydatidiform mole in Paraguay. J Reprod Med. 1990;35(1):15–8.

    PubMed  CAS  Google Scholar 

  73. Rolon PA, de Lopez BH. Epidemiological aspects of hydatidiform mole in the Republic of Paraguay (South America). Br J Obstet Gynaecol. 1977;84(11):862–4.

    PubMed  CAS  Google Scholar 

  74. Aguero O, Kizer S, Pinedo G. Hydatidiform mole in concepcion palacios maternity hospital. Am J Obstet Gynecol. 1973;116(8):1117–20.

    PubMed  CAS  Google Scholar 

  75. Martin BH, Kim JH. Changing face of gestational trophoblastic tumor. Int J Gynaecol Obstet. 1998;60 Suppl 1:S111–20.

    PubMed  Google Scholar 

  76. Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med. 1998;43(1):60–8.

    PubMed  CAS  Google Scholar 

  77. Kim SJ, Bae SN, Kim JH, Kim CJ, Han KT, Chung JK, et al. Epidemiology and time trends of gestational trophoblastic disease in Korea. Int J Gynaecol Obstet. 1998;60 Suppl 1:S33–8.

    PubMed  Google Scholar 

  78. Hando T, Ohno M, Kurose T. Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet. 1998;60 Suppl 1:S71–6.

    PubMed  Google Scholar 

  79. Kanazawa K. Trophoblastic disease: twenty years’ experience at Niigata University. Int J Gynaecol Obstet. 1998;60 Suppl 1:S97–103.

    PubMed  Google Scholar 

  80. Wang JC, Wang PH, Yuan CC. Review of trophoblastic disease at Taipei Veterans General Hospital. Zhonghua Yi Xue Za Zhi (Taipei). 2000;63(5):399–406.

    PubMed  CAS  Google Scholar 

  81. Khashoggi TY. Prevalence of gestational trophoblastic disease. A single institution experience. Saudi Med J. 2003;24(12):1329–33.

    PubMed  Google Scholar 

  82. Fukunaga M, Ushigome S, Endo Y. Incidence of hydatidiform mole in a Tokyo hospital: a 5-year (1989 to 1993) prospective, morphological, and flow cytometric study. Hum Pathol. 1995;26(7):758–64.

    PubMed  CAS  Google Scholar 

  83. Poen HT, Djojopranoto M. The possible etiologic factors of hydatidiform mole and choriocarcinoma: preliminary report. Am J Obstet Gynecol. 1965;92:510–3.

    PubMed  CAS  Google Scholar 

  84. Chan DP. Treatment of chorionepithelioma with methotrexate. Br Med J. 1962;2(5310):957–61. PMCID: 1926395.

    Google Scholar 

  85. Brewer JI, Gerbie AB. Early development of choriocarcinoma. In: Holland JF, Hreshchyshyn MM, editors. Choriocarcinoma: transactions of a conference of the international union against cancer. Berlin: Springer; 1967. p. 8.

    Google Scholar 

  86. Yen S, MacMahon B. Epidemiologic features of trophoblastic disease. Am J Obstet Gynecol. 1968;101(1):126–32.

    PubMed  CAS  Google Scholar 

  87. Aziz MF, Kampono N, Moegni EM, Sjamsuddin S, Barnas B, Samil RS. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Adv Exp Med Biol. 1984;176:165–75.

    PubMed  CAS  Google Scholar 

  88. Matalon M, Paz B, Modan M, Modan B. Malignant trophoblastic disorders. Epidemiologic aspects and relationship to hydatidiform mole. Am J Obstet Gynecol. 1972;112(1):101–6.

    PubMed  CAS  Google Scholar 

  89. MacGregor C, Ontiveros E, Vargas E, Valenzuela S. Hydatidiform mole. Analysis of 145 patients. Obstet Gynecol. 1969;33(3):343–51.

    PubMed  CAS  Google Scholar 

  90. Nielsen NH, Hansen JP. Trophoblastic tumors in Green­land. J Cancer Res Clin Oncol. 1979;95(2):177–86.

    PubMed  CAS  Google Scholar 

  91. Teoh ES, Dawood MY, Ratnam SS. Epidemiology of hydatidiform mole in Singapore. Am J Obstet Gynecol. 1971;110(3):415–20.

    PubMed  CAS  Google Scholar 

  92. Bandy LC, Clarke-Pearson DL, Hammond CB. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol. 1984;64(3):395–9.

    PubMed  CAS  Google Scholar 

  93. Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002;109(1):99–102.

    PubMed  CAS  Google Scholar 

  94. Bayatpour MRJ. Gestational trophoblastic disease among adolescents. Adolesc and Pediatr Gynecol. 1993;6:3.

    Google Scholar 

  95. La Vecchia C, Franceschi S, Parazzini F, Fasoli M, Decarli A, Gallus G, et al. Risk factors for gestational trophoblastic disease in Italy. Am J Epidemiol. 1985;121(3):457–64.

    PubMed  Google Scholar 

  96. Maudsley RF, Robertson EM. Hydatidiform mole in a woman over 52 years old. Report of a case. Obstet Gynecol. 1965;26(4):542–3.

    PubMed  CAS  Google Scholar 

  97. Di Cintio E, Parazzini F, Rosa C, Chatenoud L, Benzi G. The epidemiology of gestational trophoblastic disease. Gen Diagn Pathol. 1997;143(2–3):103–8.

    PubMed  Google Scholar 

  98. Garcia M, Romaguera RL, Romaguera C. A hydatidiform mole in a postmenopausal woman. A case report and review of the literature. Arch Pathol Lab Med. 2004;128(9):1039–42.

    PubMed  Google Scholar 

  99. Matalon M, Modan B. Epidemiologic aspects of hydatidiform mole in Israel. Am J Obstet Gynecol. 1972;112(1):107–12.

    PubMed  CAS  Google Scholar 

  100. Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984;63(2):140–4.

    PubMed  CAS  Google Scholar 

  101. Matsui H, Iitsuka Y, Suzuka K, Seki K, Sekiya S. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole. Hum Reprod. 2001;16(6):1274–7.

    PubMed  CAS  Google Scholar 

  102. Bagshawe KD. Recent observations related to the chemotherapy and immunology of gestational choriocarcinoma. Adv Cancer Res. 1973;18:231–63.

    PubMed  CAS  Google Scholar 

  103. Cheah PL, Looi LM, Sivanesaratnam V. Hydatidiform molar pregnancy in malaysian women: a histopathological study from the University Hospital, Kuala Lumpur. Malays J Pathol. 1993;15(1):59–63.

    PubMed  CAS  Google Scholar 

  104. Matsuura J, Chiu D, Jacobs PA, Szulman AE. Complete hydatidiform mole in Hawaii: an epidemiological study. Genet Epidemiol. 1984;1(3):271–84.

    PubMed  CAS  Google Scholar 

  105. Natoli WJ, Rashad MN. Hawaiian moles. Am J Roentgenol Radium Ther Nucl Med. 1972;114(1):142–4.

    PubMed  CAS  Google Scholar 

  106. McCorriston CC. Racial incidence of hydatidiform mole. A study in a contained polyracial community. Am J Obstet Gynecol. 1968;101(3):377–82.

    PubMed  CAS  Google Scholar 

  107. Jacobs PA, Hunt PA, Matsuura JS, Wilson CC, Szulman AE. Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol. 1982;89(4):258–66.

    PubMed  CAS  Google Scholar 

  108. Gul T, Yilmazturk A, Erden AC. A review of trophoblastic diseases at the medical school of Dicle University. Eur J Obstet Gynecol Reprod Biol. 1997;74(1):37–40.

    PubMed  CAS  Google Scholar 

  109. Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):837–47.

    PubMed  Google Scholar 

  110. Teoh ES, Dawood MY, Ratnam SS. Observations on choriocarcinoma in Singapore. Obstet Gynecol. 1972;40(4):519–24.

    PubMed  CAS  Google Scholar 

  111. Martin PM. High frequency of hydatidiform mole in native Alaskans. Int J Gynaecol Obstet. 1978;15(5):395–6.

    PubMed  CAS  Google Scholar 

  112. Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007;71(1):25–34.

    PubMed  CAS  Google Scholar 

  113. The Joint Project for Study of Choriocarcinoma and Hydatidiform Mole in Asia. Geographic variation in the occurrence of hydatidiform mole and choriocarcinoma. Ann N Y Acad Sci. 1959;80:178–95.

    Google Scholar 

  114. Pour-Reza M, Agheli N, Vaghefi SB. Serum creatinine, urea, and protein level changes in hydatidiform mole. JAMA. 1974;230(4):580–1.

    PubMed  CAS  Google Scholar 

  115. Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP. Risk factors for ­complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985;152(8):1016–20.

    PubMed  CAS  Google Scholar 

  116. Parazzini F, La Vecchia C, Mangili G, Caminiti C, Negri E, Cecchetti G, et al. Dietary factors and risk of trophoblastic disease. Am J Obstet Gynecol. 1988;158(1):93–9.

    PubMed  CAS  Google Scholar 

  117. Bracken MB. Incidence of hydatidiform mole. Am J Obstet Gynecol. 1988;158(4):1016–7.

    PubMed  CAS  Google Scholar 

  118. Palmer JR, Driscoll SG, Rosenberg L, Berkowitz RS, Lurain JR, Soper J, et al. Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst. 1999;91(7):635–40.

    PubMed  CAS  Google Scholar 

  119. Brinton LA, Wu BZ, Wang W, Ershow AG, Song HZ, Li JY, et al. Gestational trophoblastic disease: a case-control study from the People’s Republic of China. Am J Obstet Gynecol. 1989;161(1):121–7.

    PubMed  CAS  Google Scholar 

  120. Baltazar JC. Epidemiological features of choriocarcinoma. Bull World Health Organ. 1976;54(5):523–32. PMCID: 2366480

    Google Scholar 

  121. Curry SL, Schlaerth JB, Kohorn EI, Boyce JB, Gore H, Twiggs LB, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a gynecologic oncology group study). Am J Obstet Gynecol. 1989;160(4):805–9; discussion 9–11.

    Google Scholar 

  122. Deicas RE, Miller DS, Rademaker AW, Lurain JR. The role of contraception in the development of postmolar gestational trophoblastic tumor. Obstet Gynecol. 1991;78(2):221–6.

    PubMed  CAS  Google Scholar 

  123. Morrow P, Nakamura R, Schlaerth J, Gaddis Jr O, Eddy G. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Am J Obstet Gynecol. 1985;151(7):906–14.

    PubMed  CAS  Google Scholar 

  124. Rosenberg L, Palmer JR, Shapiro S. Gestational trophoblastic disease and use of oral contraceptives. Am J Obstet Gynecol. 1989;161(4):1087–8.

    PubMed  CAS  Google Scholar 

  125. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39(3):155–62.

    PubMed  CAS  Google Scholar 

  126. Matalon M, Modan M, Paz B, Modan B. Trophoblastic disorders in Istael. Harefuah. 1972;83(12):566–8.

    PubMed  CAS  Google Scholar 

  127. Bracken MB, Brinton LA, Hayashi K. Epidemiology of hydatidiform mole and choriocarcinoma. Epidemiol Rev. 1984;6:52–75.

    PubMed  CAS  Google Scholar 

  128. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29(7):942–7.

    PubMed  Google Scholar 

  129. Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108(1):176–87.

    PubMed  Google Scholar 

  130. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001;11(1):73–7.

    PubMed  CAS  Google Scholar 

  131. Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet. 2003;83 Suppl 1:175–7.

    PubMed  Google Scholar 

  132. Acosta-Sison H. Trophoblastic or chorionic tumours as observed in the Philippines. In: Hollander JF, Hreshchyshyn MM, editors. Choriocarcinoma: transactions of a conference of the international union against cancer. Berlin: Springer; 1967.

    Google Scholar 

  133. Chun D, Braga C, Chow C, Lok L. Clinical observations on some aspects of hydatidiform moles. J Obstet Gynaecol Br Commonw. 1964;71:180–4.

    PubMed  CAS  Google Scholar 

  134. Chan DP. Chorionepithelioma: a study of 41 cases. Br Med J. 1962;2(5310):953–7. PMCID: 1926430.

    Google Scholar 

  135. King G. Hydatidiform mole and chorion-epithelioma–the problem of the borderline case. Proc R Soc Med. 1956;49(7):381–90. PMCID: 1889150.

    Google Scholar 

  136. Das PC. Hydatidiform mole: a statistical and clinical study. J Obstet Gynaecol. 1938;45:6.

    Google Scholar 

  137. Marquez-Monter H, de la Vega GA, de la Vega GA, Robles M, Robles M, Bolio-Cicero A, et al. Epidemiology and pathology of hydatidiform mole in the general hospital in Mexico. Am J Obstet Gynecol. 1963;85:8.

    Google Scholar 

  138. Lara FM, Alvarado AM, Candelaria M, Arce CS. Gestational trophoblastic disease. Experience at National Institute of Cancerology. Ginecol Obstet Mex. 2005;73(6):308–14.

    PubMed  Google Scholar 

  139. Javey H, Sajadi H. Hydatidiform mole in southern Iran: a statistical survey of 113 cases. Int J Gynaecol Obstet. 1978;15(5):390–5.

    PubMed  CAS  Google Scholar 

  140. Ishizuka N. Studies on trophoblastic neoplasia. Gann Monogr. 1976;18:14.

    Google Scholar 

  141. Mills W. Chorion-Carcinoma in the Midlands. Clin Radiol. 1964;15:260–2.

    PubMed  CAS  Google Scholar 

  142. Kolstad P, Hognestad J. Trophoblastic tumours in Norway. Acta Obstet Gynecol Scand. 1965;44:80–8.

    PubMed  CAS  Google Scholar 

  143. Leighton PC. Trophoblastic disease in Uganda. Am J Obstet Gynecol. 1973;117(3):341–4.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Yale University School of Medicine, 310 Cedar Street, 254B, New Haven, CT, 06520-8023, USA

    Pei Hui MD, PhD

Authors
  1. Pei Hui MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pei Hui MD, PhD .

Editor information

Editors and Affiliations

  1. , Department of Pathology, Yale University School of Medicine, 310 Cedar St., New Haven, 06520-8023, USA

    Pei Hui

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hui, P. (2012). Gestational Trophoblastic Disease: General Aspects. In: Hui, P. (eds) Gestational Trophoblastic Disease. Current Clinical Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-61779-394-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-394-3_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-61779-393-6

  • Online ISBN: 978-1-61779-394-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation